Development asset linked to Rapport Therapeutics in public FDA and regional records.
pharma · Epilepsy · Bipolar 1 Disorder · RAPP
Rapport Therapeutics
Rapport Therapeutics drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Boston, USA HQ
2022 Founded
94 Employees
Public company Type
RAPP · NYSE Ticker
Company details
- Status
- Public
- HQ
- Boston, USA
- Founded
- 2022
- Employees
- 94
- Programs
- 5
- Drugs
- 1
- Patents
- 1
Rapport Therapeutics pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Rapport Therapeutics drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.